Skip to main content
Top
Published in: Dermatology and Therapy 1/2016

Open Access 01-03-2016 | Original Research

Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis with Topical Steroid Addiction

Author: Mototsugu Fukaya

Published in: Dermatology and Therapy | Issue 1/2016

Login to get access

Abstract

Introduction

Though topical steroid addiction (TSA) in patients with atopic dermatitis (AD) has been recently discussed as a clinical problem, there are very few studies about its mechanism. The purpose of this study was to elucidate histological and immunohistological characteristics of TSA using anti-cortisol antibody.

Methods

Skin biopsy specimen from eight patients with AD was stained by anti-cortisol antibody (Biorbyt, orb79379). Subjects consisted of a child patient with a short history of topical corticosteroids (TCS) application, an adult patient with a long history of TCS application, and six adult patients who have experienced topical steroid withdrawal (TSW) and the rebound phenomenon.

Results

The staining in the epidermis by anti-cortisol antibody presented patchy defects in the child patient, the patient with a long history of TCS application, and two patients at the rebound period. Parakeratosis with poor formation of corneal layer was obvious in the child patient, the patient with a long history of TCS application, two patients recovered from TSA, and two patients at the rebound period.

Conclusion

Prolonged application of TCS might suppress the cortisol production of keratinocytes which is poorly developed at the early ages before childhood and completed naturally as to growth. Rebound phenomenon after TSW can occur due to the relative insufficiency of cortisol in the epidermis and the immature corneal layer formation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cirillo N, Prime SS. Keratinocytes synthesize and activate cortisol. J Cell Biochem. 2011;112(6):1499–505.CrossRefPubMed Cirillo N, Prime SS. Keratinocytes synthesize and activate cortisol. J Cell Biochem. 2011;112(6):1499–505.CrossRefPubMed
2.
go back to reference Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, Li W, Janjetovic Z, Postlethwaite A, Zouboulis CC, Tuckey R, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107–23.CrossRefPubMedPubMedCentral Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, Li W, Janjetovic Z, Postlethwaite A, Zouboulis CC, Tuckey R, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107–23.CrossRefPubMedPubMedCentral
3.
go back to reference Takei K, Denda S, Kumamoto J, Denda M. Low environmental humidity induces synthesis and release of cortisol in an epidermal organotypic culture system. Exp Dermatol. 2013;22(10):662–4.CrossRefPubMed Takei K, Denda S, Kumamoto J, Denda M. Low environmental humidity induces synthesis and release of cortisol in an epidermal organotypic culture system. Exp Dermatol. 2013;22(10):662–4.CrossRefPubMed
5.
go back to reference Rapaport MJ, Rapaport V. Prolonged erythema after facial laser resurfacing or phenol peel secondary to corticosteroid addiction. Dermatol Surg. 1999;25(10):781–4 (discussion 785).CrossRefPubMed Rapaport MJ, Rapaport V. Prolonged erythema after facial laser resurfacing or phenol peel secondary to corticosteroid addiction. Dermatol Surg. 1999;25(10):781–4 (discussion 785).CrossRefPubMed
6.
go back to reference Hajar T, Leshem YA, Hanifin JM, the National Eczema Association Task Force, et al. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541–9.CrossRefPubMed Hajar T, Leshem YA, Hanifin JM, the National Eczema Association Task Force, et al. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541–9.CrossRefPubMed
7.
go back to reference Fukaya M, Sato K, Sato M, et al. Topical steroid addiction in atopic dermatitis. Drug Healthc Patient Saf. 2014;14(6):131–8.CrossRef Fukaya M, Sato K, Sato M, et al. Topical steroid addiction in atopic dermatitis. Drug Healthc Patient Saf. 2014;14(6):131–8.CrossRef
8.
go back to reference Sheu HM, Tai CL, Kuo KW, Yu HS, Chai CY. Modulation of epidermal terminal differentiation in patients after long-term topical corticosteroids. J Dermatol. 1991;18(8):454–64.CrossRefPubMed Sheu HM, Tai CL, Kuo KW, Yu HS, Chai CY. Modulation of epidermal terminal differentiation in patients after long-term topical corticosteroids. J Dermatol. 1991;18(8):454–64.CrossRefPubMed
9.
go back to reference Sheu HM, Chang CH. Alterations in water content of the stratum corneum following long-term topical corticosteroids. J Formos Med Assoc. 1991;90(7):664–9.PubMed Sheu HM, Chang CH. Alterations in water content of the stratum corneum following long-term topical corticosteroids. J Formos Med Assoc. 1991;90(7):664–9.PubMed
10.
go back to reference McIntosh HW, Holmes CB. Some evidence suggesting the suppression of adrenocortical function by cortisone. Lancet. 1951;2(6693):1061–4.CrossRefPubMed McIntosh HW, Holmes CB. Some evidence suggesting the suppression of adrenocortical function by cortisone. Lancet. 1951;2(6693):1061–4.CrossRefPubMed
11.
go back to reference Zheng PS, Lavker RM, Lehmann P, Kligman AM. Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol. 1984;82(4):345–52.CrossRefPubMed Zheng PS, Lavker RM, Lehmann P, Kligman AM. Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol. 1984;82(4):345–52.CrossRefPubMed
Metadata
Title
Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis with Topical Steroid Addiction
Author
Mototsugu Fukaya
Publication date
01-03-2016
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2016
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-016-0096-7

Other articles of this Issue 1/2016

Dermatology and Therapy 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.